Articles by Disease (Endocrine Cancers)

Tumor Cell Hypoxia and the Hypoxia-Response Signaling System as a Target for Prostate Cancer Therapy

Journal: Current Drug Targets
Volume: 4
Page: 191-196
Author(s): Aristotelis G. Anastasiadis, Debra L. Bemis, Brian C. Stisser, Laurent Salomon, Mohamed A. Ghafar and Ralph Buttyan

Antisense Targets to Enhance Hormone and Cytotoxic Therapies in Advanced Prostate Cancer

Journal: Current Drug Targets
Volume: 4
Page: 209-221
Author(s): Martin Gleave, Colleen Nelson and Kim Chi

From TGF-β to Cancer Therapy

Journal: Current Drug Targets
Volume: 4
Page: 243-250
Author(s): Xuemei Huang and Chung Lee

Gene Therapy Targeting in the Central Nervous System

Journal: Current Gene Therapy
Volume: 3
Page: 127-145
Author(s): Jorge A. Benitez and Jose Segovia

Inhibitors of 17β-Hydroxysteroid Dehydrogenases

Journal: Current Medicinal Chemistry
Volume: 10
Page: 453-477
Author(s): Donald Poirier

The Role of Melanocortin Peptides and Receptors in Regulation of Energy Balance

Journal: Current Pharmaceutical Design
Volume: 9
Page: 627-641
Author(s): Ildiko Antal Zimanyi and Mary Ann Pelleymounter

Vascular Endothelial Cell Growth Factor (VEGF), An Emerging Target for Cancer Chemotherapy

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 3
Page: 95-117
Author(s): S. Shinkaruk, M. Bayle, G. Lain and G. Deleris

Unfolding the Pathophysiological Role of Bioactive Lysophospholipids

Journal: Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume: 3
Page: 23-32
Author(s): Yan Xu, Yi-jin Xiao, Kui Zhu, Linnea M. Baudhuin, Jun Lu, Guiying Hong, Kwan-sik Kim, Kelly L. Cristina, Li Song and Freager S. Williams

subject Index To Volume 2

Journal: Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume: 3
Page: 95-97
Author(s): Bentham Science Publishers

Human Kallikreins: Common Structural Features, Sequence Analysis and Evolution

Journal: Current Genomics
Volume: 4
Page: 147-165
Author(s): George M. Yousef and Eleftherios P. Diamandis